TABLE 1.
Characteristic | Value | MVa |
---|---|---|
Median age (range) (yr) | 57 (0–90) | 0 |
Sex ratio (male/female) | 2.9 | 0 |
Underlying disease, no. (%) | ||
HIV infection | 40 (27.4) | 2 |
CD4+ T-cell, mean/mm3 (range) | 56 (1–1,240) | 2 |
Solid cancer | 25 (17.1) | 2 |
Solid organ transplantation | 9 (6.2) | 2 |
Hematologic malignancy | 45 (30.8) | 2 |
Bone marrow transplant | 3 (2.1) | 2 |
Autoimmune or inflammatory disease | 11 (7.8) | 7 |
COPDb | 19 (13.0) | 2 |
Other | 10 (6.8) | |
Concomitant treatment, no. (%) | ||
Anti-tumor chemotherapy | 48 (32.7) | 1 |
Immunosuppressive agents (other than chemotherapy or corticosteroids) | 18 (12.2) | 0 |
Long-term corticosteroid therapy | 6 (4.1) | 0 |
Clinical signs, no. (%) | ||
Cough | 74 (54.8) | 13 |
Fever | 88 (65.2) | 13 |
Dyspnea | 92 (67.6) | 12 |
Radiological findings (chest radiography or computed tomography scan), no. (%) | ||
Abnormalities consistent with PCP | 113 (79.6) | 6 |
No abnormality or abnormalities not consistent with PCP | 29 (20.4) | 6 |
Curative treatment of PCP | 78 (52.7) | 0 |
Other documented etiology for the pneumonia | 33 (26.2) | 22 |
MV, missing value.
COPD, chronic obstructive pulmonary disease.